EgyptEgypt is Africa's largest pharmaceutical market and a strategic gateway to the Middle East and North Africa. Taevas delivers end-to-end regulatory, commercial, and distribution support so life-sciences brands can enter with speed and certainty.
Select an industry to see regulatory pathways, services, and how Taevas supports your Egypt market entry.
Egyptian Drug Authority (EDA) — Medical Device Sector
Egypt's medical device sector is growing rapidly, driven by expanding hospital infrastructure, a rising middle class, and government investment in universal health coverage. The Egyptian Drug Authority (EDA) oversees all device registrations under a risk-based classification system spanning Class A to Class D. Taevas manages the full registration lifecycle, from dossier preparation and local agent appointment to post-market surveillance and ongoing compliance.
All medical devices must be classified by risk level (Class A through D) and registered with the EDA Medical Device Sector before any import or sale. Taevas prepares and submits the complete technical dossier aligned with EDA requirements.
Foreign manufacturers must appoint an EDA-recognised local authorised representative in Egypt who assumes regulatory responsibility for the product. Taevas provides in-country representation to satisfy this requirement.
Each shipment of registered medical devices requires an import permit issued by EDA and clearance through the General Organisation for Export and Import Control (GOEIC). Taevas coordinates both to prevent port delays.
EDA mandates ongoing adverse event reporting, periodic safety updates, and renewal of device registrations. Taevas maintains a continuous vigilance programme to keep your products compliant and on the market.
Taevas has built a proven in-country team in Egypt with deep EDA relationships, established distributor networks, and a track record of getting life-sciences brands to market faster than the industry average.
Our Egypt regulatory team has hands-on experience with EDA dossier submissions across pharmaceuticals, medical devices, cosmetics, and food supplements, minimising clock-stops and approval delays.
Egypt's location and trade agreements make it a natural hub for brands expanding across North Africa and the wider Arab world. Taevas leverages this geography to build scalable regional strategies from an Egypt base.
Our pre-built relationships with EDA reviewers, customs brokers, and logistics partners mean we can compress registration and importation timelines significantly compared to a cold-start market entry.
Taevas maintains vetted partnerships with leading Egyptian distributors across hospital, pharmacy, modern trade, and e-commerce channels, giving your brand immediate commercial reach on day one.
Our Egypt team has cultivated relationships with leading clinicians, pharmacists, nutritionists, and beauty professionals who can champion your brand within their professional communities.
From first regulatory submission through to in-market sales performance reporting, Taevas takes full ownership of every milestone so your head office has a single accountable partner in Egypt.
Speak with our Egypt specialists today and receive a tailored market entry roadmap covering regulatory timelines, commercial strategy, and distribution options specific to your product category.